Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where P. Kisza is active.

Publication


Featured researches published by P. Kisza.


Journal of Hepatocellular Carcinoma | 2017

A Phase I trial using local regional treatment, nonlethal irradiation, intratumoral and systemic polyinosinic-polycytidylic acid polylysine carboxymethylcellulose to treat liver cancer: in search of the abscopal effect

Andrew N. de la Torre; Sohail Contractor; Ismael Castaneda; Charles S Cathcart; Dolly Razdan; David Klyde; P. Kisza; Sharon Gonzales; Andres M. Salazar

Purpose To determine the safety of an approach to immunologically enhance local treatment of hepatocellular cancer (HCC) by combining nonlethal radiation, local regional therapy with intratumoral injection, and systemic administration of a potent Toll-like receptor (TLR) immune adjuvant. Methods Patients with HCC not eligible for liver transplant or surgery were subject to: 1) 3 fractions of 2-Gy focal nonlethal radiation to increase tumor antigen expression, 2) intra-/peri-tumoral (IT) injection of the TLR3 agonist, polyinosinic-polycytidylic acid polylysine carboxymethylcellulose (poly-ICLC), to induce an immunologic “danger” response in the tumor microenvironment with local regional therapy, and 3) systemic boosting of immunity with intramuscular poly-ICLC. Primary end points were safety and tolerability; secondary end points were progression-free survival (PFS) and overall survival (OS) at 6 months, 1 year, and 2 years. Results Eighteen patients with HCC not eligible for surgery or liver transplant were treated. Aside from 1 embolization-related severe adverse event, all events were ≤grade II. PFS was 66% at 6 months, 39% at 12 months, and 28% at 24 months. Overall 1-year survival was 69%, and 2-year survival 38%. In patients <60 years old, 2-year survival was 62.5% vs. 11.1% in patients aged >60 years (P<0.05). Several patients had prolonged PFS and OS. Conclusion Intra-tumoral injection of the TLR3 agonist poly-ICLC in patients with HCC is safe and tolerable when combined with local nonlethal radiation and local regional treatment. Further work is in progress to evaluate if this approach improves survival compared to local regional treatment alone and characterize changes in anticancer immunity.


Vascular and Endovascular Surgery | 2018

Endovascular Approach for Management of Bullet Embolization to the Heart

Alireza Mojtahedi; S. Contractor; P. Kisza

Bullet embolization to the right heart through the vasculature is seen infrequently in cases presenting with penetrating trauma. Patients with unstable hemodynamic status are managed operatively. For a patient with stable hemodynamic parameters, diagnostic evaluation such as computed tomography angiogram, echocardiogram, or angiography could be performed to select the best treatment option. Endovascular treatment is employed infrequently in these cases but can be a viable option for select patients. We present a case of a bullet embolus to the right ventricle treated successfully with endovascular approach and discuss the technical aspects of this approach.


Trauma | 2015

Endovascular coil embolisation of a giant pulmonary artery pseudoaneurysm from a gunshot wound

Abhishek Kumar; John Yoon; Anastasia Kunac; S. Contractor; P. Kisza

A 38-year-old female was brought to the trauma emergency room after sustaining multiple gunshot wounds to the right chest and abdomen. She had pulmonary contusions involving the right lung and a haemopneumothorax initially managed with chest tube placement. A few weeks into her hospitalisation, she was found to have a giant right pulmonary artery pseudoaneurysm, which corresponded to a bullet tract. The pseudoaneurysm was causing a steal phenomenon and impaired perfusion of the right middle lobe and right lower lobe. Endovascular coil embolisation of the pseudoaneurysm was performed with restoration of perfusion to the right lung.


Journal of Vascular and Interventional Radiology | 2009

Safety and Feasibility of Outpatient Transcatheter Hepatic Arterial Embolization for Hepatocellular Carcinoma

Jason W. Mitchell; William G. O'Connell; P. Kisza; David P. Klyde; Sharon F. Gonzalez; Pierre D. Maldjian; Philip Bahramipour; S. Contractor


Journal of Vascular and Interventional Radiology | 2015

Use of PhaSeal Transfer System during Chemoembolization to Prevent Unintentional Leakage of Chemotherapeutic Agents during Preparation and Delivery

S. Contractor; A. Kumar; Michelle Phillip; Dhruv Patel; Jenicka Karcich; P. Kisza


Journal of Vascular and Interventional Radiology | 2017

Phase1 study of immune-enhanced locoregional therapy: hepatic artery embolization combined with intra-tumoral and systemic poly-ICLC to treat liver cancer

A. Jon; P. Kisza; S. Contractor; A. N. De La Torre


Journal of Vascular and Interventional Radiology | 2016

Optimal obliquities for angiographic evaluation of the major vessels

P. Thomas; P. Kisza; S. Contractor


Journal of Vascular and Interventional Radiology | 2016

Educational ExhibitAbstract No. 547 - Optimal obliquities for angiographic evaluation of the major vessels

P. Thomas; P. Kisza; S. Contractor


Journal of Vascular and Interventional Radiology | 2016

Abstract No. 547 – Optimal obliquities for angiographic evaluation of the major vessels

P. Thomas; P. Kisza; S. Contractor


Journal of Vascular and Interventional Radiology | 2016

Troubled waters: renal vascular emergencies: imaging and management

P. Thomas; X. Chin; P. Kisza; S. Contractor

Collaboration


Dive into the P. Kisza's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

A. Kumar

Beth Israel Medical Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge